Regulatory concerns rise over virtual obesity drug prescription models

Virtual clinics are facing increased scrutiny regarding the safety and oversight of prescribing weight-loss medications. It remains unclear if current regulatory frameworks are sufficient to mitigate risks associated with remote access to potent pharmaceuticals.